Seminars in Nuclear Medicine

Article	Citations
Theranostics in Lung Neuroendocrine Tumors	140
Letter from the Guest Editors	123
Letter from the Editors	107
Non-FDG hypoxia tracers	71
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	58
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	54
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	54
PET/CT in the Imaging of CNS Tumors	47
Sentinel Lymph Node Methods in Breast Cancer	45
Imaging of Invasive Fungal Infections- The Role of PET/CT	43
FAPI-PET in Cardiovascular Disease	42
Autoimmune Thyroid Diseases	42
New Promising Targets for Imaging in Cardiovascular Diseases	42
The Role of Nuclear Medicine in Benign Thyroid Disease	40
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	38
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	37
Prognostic Value of PSMA PET/CT in Prostate Cancer	37
Imaging for Radiation Planning in Breast Cancer	36
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	35
The Evolution of Artificial Intelligence in Nuclear Medicine	35
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	35
Molecular Imaging in Inflammatory Bowel Disease	35
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	33
Total-Body PET/CT: A Role of Artificial Intelligence?	33
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers	32

Global experience in brain amyloid imaging	31
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	31
New Approaches for Imaging Bacteria	29
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-19	29
PET/MR Technology: Advancement and Challenges	28
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	27
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	26
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	25
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	25
Expanding Role for Gallium-68 PET Imaging in Oncology	25
Letter From the Editors	24
Letter from the Guest Editors	24
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	23
Update on Pediatric Nuclear Medicine in Acute Care	23
Use of Radionuclide-Based Imaging Methods in Breast Cancer	23
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	22
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	21
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	21
18F-Fluoride PET/CT—Updates	21
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	21
Impact of COVID-19 on Nuclear Medicine in Asia	20
Total-body PET/CT – First Clinical Experiences and Future Perspectives	20
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	19
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	19
Radiolabeled Somatostatin Analogs for Cancer Imaging	19
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	19
Letter from the Editors	19
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	18
FDG PET/CT for Staging Lung Carcinoma: An Update	18
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	18
Safe Pulmonary Scintigraphy in the Era of COVID-19	17
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	17
The Clinical Utility of Molecular Imaging in COVID-19: An Update	17
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	17
Artificial Intelligence Augmented Cerebral Nuclear Imaging	17
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	17
Targeted Radiopharmaceutical Therapy for Bone Metastases	17
Functional Imaging of Testicular Torsion	17
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment	17
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	16
The Impact of COVID-19 on Nuclear Medicine in Europe	16
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget	16
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies	16
Letter from the Editors	15
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	15
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	15
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	15
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case	15
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	15
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	14

A Role of Non-FDG Tracers in Lung Cancer?	14
Prostate Cancer Theranostics With 177Lu-PSMA	14
Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	14
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	14
PET/CT Variants and Pitfalls in Gynecological Cancers	14
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy	14
FDG-PET/CT of COVID-19 and Other Lung Infections	14
Letter From the Editors	13
Cardiac PET/MRI: Recent Developments and Future Aspects	13
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	13
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	13
Radiation Dose to Pediatric Patients From Radiopharmaceuticals	13
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	13
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	13
Letter From the Guest Editors	13
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	12
Neuroimaging of Mild Traumatic Injury	12
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	12
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	12
Total Body PET/CT: A Role in Musculoskeletal Diseases	12
Advances in PET/CT Technology: An Update	12
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	12
Letter from the Editors	12
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?	12
Preclinical Evaluation of Novel PET Probes for Dementia	11
Letter from the Editors	11
Pitfalls on PET/MRI	11
Cardiovascular Imaging in Women	11
Letter from the Editors	11
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	11
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting	11
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	10
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	10
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	10
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	10
Parathyroid Imaging	10
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	10
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma	10
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	10
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	10
Letter From the Editors	10
Letter from the Editors	10
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	10
New Targets for Imaging in Nuclear Medicine	10
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	9
Molecular imaging Theranostics of Neuroendocrine Tumors	9
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	9
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	9
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	9
PET/CT Variants and Pitfalls in Breast Cancers	9
Imaging of Bone Metastases in Breast Cancer	9
AI in SPECT Imaging: Opportunities and Challenges	9
Current and Future Perspectives of PDL1 PET and SPECT Imaging	9
Pitfalls of Radionuclide Renal Imaging in Pediatrics	9
Clinical Management of COVID-19 Patients – An Update	9
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	9
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	8
Combination Strategies and Targeted Radionuclide Therapies	8
Imaging Approach to Disease of the Pleura	8
Letter from the Editors	8
Letter from the Editors	8
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	8
Advancement in Production of Radiotracers	7
Advances in PSMA Alpha Theragnostics	7
The Current Role of Tau PET Imaging in Neurodegeneration	7
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	7
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients	7
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	7
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	7
Letter From the Editors	7
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	7
Letter from the Editors	7
FDG PET/CT Imaging of Sarcoidosis	7
Application of Deep Learning in Breast Cancer Imaging	7
Letter From the Editors	7
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	7
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	7
Total Body PET-CT Protocols in Oncology	6
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	6
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	6

PET/CT in Bladder Cancer: An Update	6
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	6
The Impact of Radiopharmaceutical Therapy on Renal Function	6
Clinical Use of PET/MR in Oncology: An Update	6
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	6
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	6
18F-FDG PET/CT for Response Assessment in Lung Cancer	6
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	6
PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas	6
Molecular Imaging of Tuberculosis	6
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	6
Molecular Imaging of Fever of Unknown Origin: An Update	6
Molecular Imaging of Pituitary Tumors	5
Mucin-Targeted Antibodies for Ovarian Cancer	5
How to Report PSMA PET	5
Potential of Technetium and Rhenium Theranostics	5
[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive Review	5
[15O]H2O PET: Potential or Essential for Molecular Imaging?	5
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies	5
Impact of PSMA PET on Radiation Oncology Planning	5
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	5
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?	5
Present status and future trends in molecular imaging of lymphocytes	5
“PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”	5
Preclinical Imaging of Prostate Cancer	5
Total-Body PET/CT: Pros and Cons	5
Vulnerable Plaque Imaging	5
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	5
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases	5
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls	5
SPECT and PET Radiotracers in Renal Imaging	5
PET/CT in Hodgkin Lymphoma: An Update	5